Development of Extragenital Lichen Sclerosus in Malignant Melanoma Patients Treated With Ipilimumab in Combination With Nivolumab

The immune checkpoint inhibitors opened a new era for the treatment of melanoma. Nowadays, combined immune checkpoint inhibitors are administered to provide additive or synergistic effects on anti-melanoma immunity. The use of these drugs comes with serious adverse events related to excessive immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyed Jafari, S. Morteza, Feldmeyer, Laurence, Hunger, Robert E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577175/
https://www.ncbi.nlm.nih.gov/pubmed/33117707
http://dx.doi.org/10.3389/fonc.2020.573527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577175/
https://www.ncbi.nlm.nih.gov/pubmed/33117707
http://dx.doi.org/10.3389/fonc.2020.573527

Ejemplares similares